SYNBIOFF
Live / Registered — Registered (as of 21 Nov 2023)
What this means for you
Registered since 21 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79338517
- Registration number
- 7220430
- Mark type
- Stylized text
- Filed
- 01 Mar 2022
- Published for opposition
- 05 Sept 2023
- Registered
- 21 Nov 2023
- Attorney of record
- Robert S. Broder
Goods and services
- Class 001 — Chemicals: Probiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticals
- Class 005 — Pharmaceuticals: Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, respiratory diseases, asthma, allergic rhinitis, viral infections, gastro-intestinal diseases, halitosis, viral diseases, autoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infections, seasonal illness, common colds, cardiovascular disease, gastro-intestinal or local dysbiosis, allergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposes, namely, for gastro-intestinal, immunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticals, namely, lipid lowering agents; milk ferments for pharmaceutical purposes
Owner
- SYNBALANCE SRL, IT
- SYNBALANCE SRL, IT
- SYNBALANCE SRL, IT
Prosecution history
- 18 Mar 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Feb 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Feb 2024 — FINAL DISPOSITION PROCESSED
- 21 Feb 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 Sept 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Sept 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 05 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Sept 2023 — PUBLISHED FOR OPPOSITION
- 04 Sept 2023 — NOTIFICATION PROCESSED BY IB
- 16 Aug 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 16 Aug 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 16 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED